Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010
Utility of quantitative T-cell responses versus unstimulated interferon-gamma for the diagnosis of pleural tuberculosis Source: Eur Respir J 2009; 34: 1118-1126 Year: 2009
Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004
Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 453s Year: 2005
Adenosine deaminase (ADA) in diagnosis of tuberculous pleural effusions in a developing country and region with average incidence of pulmonary tuberculosis Source: Annual Congress 2007 - Immunology and genetics of tuberculosis Year: 2007
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM) Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004
Serum and pleural fluid cytokines in pleural tuberculosis with and without lung parenchyma involvement Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011
Pleural ADA activity in the diagnosis of pleural tuberculosis in France Source: Annual Congress 2010 - Extrapulmonary tuberculosis Year: 2010
The significance of serum CA-125 and various tumour markers in pulmonary and pleural tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 156s Year: 2003
Biomarkers of infection for the differential diagnosis of pleural effusions Source: Eur Respir J 2009; 34: 1383-1389 Year: 2009
Is pleural VEGF a useful parameter? Source: Annual Congress 2007 - Pleural malignancy Year: 2007
Does the age affect the diagnostic yield of different biomarkers in differentiation between tuberculous and non-tuberculous pleural effusions? Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017
A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma Source: Eur Respir J 2010; 36: 1099-1105 Year: 2010
Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Adenosine deaminase level of pleural fluids in the differential diagnosis of tuberculosis and malignant pleural fluids: a new cut-off value suggestion Source: Eur Respir J 2002; 20: Suppl. 38, 581s Year: 2002
Pleural and systemic cytokine expression profiles in patients with lung cancer Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
Analysis of T-cell subsets in patients with tuberculous pleural effusions Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis Year: 2005
Pleural fluid leptin level for the differential diagnosis of pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006
Variability of the sensitivity of three tests for the diagnosis of pleural TB according to the findings in pleural tissue Source: Eur Respir J 2005; 26: Suppl. 49, 241s Year: 2005